Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
about
Vascular CXCR4 expression - a novel antiangiogenic target in gastric cancer?AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.Antitumor effects of cecropin B-LHRH' on drug-resistant ovarian and endometrial cancer cells.The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine.Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215.Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.Receptor-mediated tumor targeting based on peptide hormones.Gonadotropin-releasing hormone targeting for gonadotroph ablation: an approach to non-surgical sterilization.Drug delivery and release systems for targeted tumor therapy.Controlling toxicity of Peptide-drug conjugates by different chemical linker structures.Comparative in vitro biological evaluation of daunorubicin containing GnRH-I and GnRH-II conjugates developed for tumor targeting.Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model.In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites.Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238.Probing the GnRH receptor agonist binding site identifies methylated triptorelin as a new anti-proliferative agent.Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation.Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.On the design principles of peptide-drug conjugates for targeted drug delivery to the malignant tumor site.
P2860
Q33553482-8F29E56C-0D40-47E6-8976-9E32AF15ABD8Q34274245-D8FCAD47-D427-4592-AD00-80A698F97281Q35972278-018BB66C-BBE7-4958-B40F-42D1FFA60E48Q36147300-14287679-78B5-48D9-8DBB-A139A2A27B6DQ36202016-5D97DE0B-F997-4877-B77B-BA93A456A220Q36644341-51D1CA4C-3222-43A7-ABE4-0F0C70909317Q37579225-F5A9B585-D8D3-45DF-95A8-8EE41D250371Q37641368-F1054970-C06D-47F3-8A5B-577ACA1B9F76Q38029046-5FBCDC13-E9A9-4262-81B4-2A70A9702E65Q38363691-DAEAA255-767B-465F-A0EE-F24AB6130D98Q38882129-82103D24-AA99-4B0B-885A-8B169C559785Q38882916-2244A2AC-3BFD-492B-8D19-C24F1B9198A7Q39428786-B116FF0B-5CC1-432E-BAD4-F60E86A83564Q39643108-8123CCD9-B2B4-4009-B0C6-44A424F5666BQ40778582-3DBA2132-1F75-4209-8654-6BF8D7C43822Q41899896-E43BB0E8-878E-4B06-80D8-02CAE061D836Q42828662-F3DBC51C-77BF-49F7-85A0-191AEFE0A6DCQ48656281-028CC2C8-D2F3-4D5F-BFC0-4C57017B86B0Q55054276-874F763C-D9D8-4D3C-92A8-5B0CD73C8CDC
P2860
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Stability of cytotoxic luteini ...... design of preclinical studies.
@ast
Stability of cytotoxic luteini ...... design of preclinical studies.
@en
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate
@nl
type
label
Stability of cytotoxic luteini ...... design of preclinical studies.
@ast
Stability of cytotoxic luteini ...... design of preclinical studies.
@en
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate
@nl
prefLabel
Stability of cytotoxic luteini ...... design of preclinical studies.
@ast
Stability of cytotoxic luteini ...... design of preclinical studies.
@en
Stability of cytotoxic luteinizing hormone-releasing hormone conjugate
@nl
P2860
P356
P1476
Stability of cytotoxic luteini ...... design of preclinical studies
@en
P2093
P2860
P304
P356
10.1073/PNAS.97.2.829
P407
P577
2000-01-01T00:00:00Z